Osaic Holdings’s AbbVie ABBV Stock Holding History

Osaic Holdings’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-190	Closed	-$7.79K	–	7185
2023 Q4	$7.79K	Hold	190	–	–	﹤0.01%	5955
2023 Q3	$2.09K	Hold	190	–	–	﹤0.01%	6615
2023 Q2	$22.8K	Hold	190	–	–	﹤0.01%	5477
2023 Q1	$7.22K	Hold	190	–	–	﹤0.01%	6160
2022 Q4	$24K	Hold	190	–	–	﹤0.01%	5438
2022 Q3	$6K	Buy	+190	New	+$27.3K	﹤0.01%	6248
2022 Q2	–	Sell	-27	Closed	-$1K	–	7292
2022 Q1	$1K	Buy	+27	New	+$3.92K	﹤0.01%	6974
2021 Q4	–	Sell	-25	Closed	-$1K	–	7342
2021 Q3	$1K	Buy	+25	New	+$2.86K	﹤0.01%	6959
2021 Q1	–	Sell	-8	Closed	-$1K	–	6775
2020 Q4	$1K	Buy	+8	New	+$769	﹤0.01%	6160
2020 Q3	–	Sell	-6	Closed	-$1K	–	6172
2020 Q2	$1K	Hold	6	–	–	﹤0.01%	5888
2020 Q1	$2K	Buy	+6	New	+$511	﹤0.01%	5636

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Osaic Holdings's ABBV Position: Q2 2026 in Review

Osaic Holdings increased its AbbVie (ABBV) stake by 18% in Q2 2026, buying an estimated $27.7M and bringing the position to 855,570 shares worth $215M. The position accounts for 0.25% of the portfolio, ranked #70.

Osaic Holdings first reported a position in ABBV in Q1 2020 and has held it in 26 quarters since. 4,221 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Osaic Holdings held 855,570 shares of AbbVie worth $215M as of Q2 2026.
Osaic Holdings bought 128,649 AbbVie shares in Q2 2026, an estimated $27.7M.
AbbVie made up 0.25% of Osaic Holdings's portfolio in Q2 2026, its #70 holding.
Osaic Holdings first reported a position in AbbVie in Q1 2020 and has held it in 26 quarters since.
4,221 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.